The buying by both the CEO and CFO is a mildly positive signal, but the dollar amount is too small to indicate strong conviction or imminent catalyst. Traders should watch for larger purchases or upcoming clinical/data readouts that could justify increased confidence.
Price Chart
Executive Summary
Two top executives at Altimmune — the CEO and CFO — collectively purchased $79K worth of stock in early April 2026, signaling confidence in the company during a period of low insider activity. The purchases were modest in dollar value and represent a small fraction of the company's $401M market cap.
Key Financial Metrics
Key Facts
- CEO Jerome Benedict purchased 15,000 shares for $47,100 on April 1, 2026.
- CFO Gregory Weaver purchased 10,000 shares for $31,499 on April 1, 2026.
- Total open-market purchases amounted to $78,599 across two C-suite executives.
- No non-cash or derivative transactions were involved — all were direct buys.
- This marks a continuation of minor insider buying, with $167K in total buys over the past 30 days.
Financial Impact
$79K in open-market purchases, representing 0.02% of Altimmune's $401M market cap
Risk Factors
- The transaction size is below 0.1% of market cap, limiting its significance.
- No accompanying commentary or financial updates were released with the trades.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ALT-1775073960911 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 29, 2026 27d ago | 8-K | $2.97 $2.67 | ▼ −10.10% | ▼ −12.05% | $2.09 (−29.63%) |
Aug 12, 2026 10w ago | 8-K | $2.93 $3.12 | ▲ +6.48% | ▲ +6.93% | $2.09 (−28.67%) |
Aug 12, 2026 10w ago | Press Release | $2.93 $3.12 | ▲ +6.48% | ▲ +6.93% | $2.09 (−28.67%) |
Aug 6, 2026 11w ago | Institutional Cluster | $3.01 $2.88 | ▼ −4.32% | ▼ −5.53% | $2.09 (−30.56%) |
Aug 5, 2026 11w ago | Press Release | $3.03 $2.93 | ▼ −3.30% | ▼ −3.65% | $2.09 (−31.02%) |
Aug 3, 2026 12w ago | Press Release | $3.00 $3.05 | ▲ +1.67% | ▼ −0.36% | $2.09 (−30.33%) |
Jul 28, 2026 12w ago | 8-K | $2.99 $3.00 | ▲ +0.33% | ▼ −1.93% | $2.09 (−30.10%) |
May 28, 2026 21w ago | Press Release | $3.07 $2.87 | ▼ −6.51% | ▼ −6.47% | $2.09 (−31.92%) |
May 27, 2026 21w ago | Press Release | $2.98 $2.90 | ▼ −2.68% | ▼ −3.89% | $2.09 (−29.87%) |
May 13, 2026 23w ago | 8-K | $3.02 $2.74 | ▼ −9.27% | ▼ −8.11% | $2.09 (−30.79%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers